NEW DHA DERIVATIVES AND THEIR USE AS MEDICAMENTS
    26.
    发明申请
    NEW DHA DERIVATIVES AND THEIR USE AS MEDICAMENTS 审中-公开
    新的DHA衍生物及其作为药物使用

    公开(公告)号:WO2006117664A1

    公开(公告)日:2006-11-09

    申请号:PCT/IB2006/001155

    申请日:2006-05-04

    摘要: Compounds of formula (I); wherein - R 1 and R 2 are the same or different and may be selected from the group consisting of a hydrogen atom, a hydroxy group, an alkyl group, a halogen atom, an alkoxy group, an acyloxy group, an acyl group, an alkenyl group, an alkynyl group, an aryl group, an alkylthio group, an alkoxycarbonyl group, an alkylsulfmyl group, an alkylsulfonyl group, an amino group, and an alkylamino group; and - X represents a carboxylic acid group, a carboxylate group, or a carboxamide group; or any pharmaceutically acceptable salt, solvate, complex or pro-drug thereof, with the provisos that the compound of formula (I) is not (all-Z)-4,7,10,13,16,19- docosahexaenoic acid (DHA), alpha-methyl DHA, alpha-methyl DHA methyl ester, alpha-methyl DHA ethyl ester or alpha-hydroxy DHA ethyl ester, are disclosed. A fatty acid composition and a pharmaceutical composition comprising such compounds are also disclosed. The use of such compounds as medicaments, in particular for the treatment of diabetes type 2, is also disclosed.

    摘要翻译: 式(I)化合物; 其中R 1和R 2相同或不同,并且可以选自氢原子,羟基,烷基,卤素原子 烷氧基,酰氧基,酰基,烯基,炔基,芳基,烷硫基,烷氧基羰基,烷基亚磺酰基,烷基磺酰基,氨基和烷基氨基; 和-X表示羧酸基,羧酸酯基或羧酰胺基; 或其任何药学上可接受的盐,溶剂化物,络合物或前药,条件是式(I)化合物不是(全Z)-4,7,10,13,16,19-二十二碳六烯酸(DHA ),α-甲基DHA,α-甲基DHA甲基酯,α-甲基DHA乙酯或α-羟基DHA乙酯。 还公开了脂肪酸组合物和包含这些化合物的药物组合物。 还公开了使用这些化合物作为药物,特别是用于治疗2型糖尿病的化合物。